Home › Mga Karamdaman ng Isip › Florida
Pag-aaral pangklinika para sa Mga Karamdaman ng Isip sa Florida
7 pag-aaral para sa Mga Karamdaman ng Isip ang naghahanap ng mga kalahok sa mga site sa Florida.
Mga Lungsod sa Florida
Opisyal na teksto ng pag-aaral (English)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Boca Raton
- Clinical Site, Deerfield Beach
- Clinical Site, Doral
- at 11 pa
Nagre-recruitPhase 2
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06887192A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Brandon, Florida, Brandon
- Miami, Florida, Miami
- Miami, Florida, Miami
- at 4 pa
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07598708A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Hollywood
- Clinical Site, Hollywood
- Clinical Site, Miami
- at 2 pa
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07459647A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- K2 Medical Research, LLC, Maitland
- Charter Research, LLC, The Villages
Nagre-recruitPhase 1
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT06297590A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- CenExel, Hollywood
- Bioresearch Partner, Miami
- University of South Florida, Psychiatry and Behavioral Neurosciences, Tampa
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 11, 2026 · NCT06524830A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
- Vistagen Clinical Site, Largo
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Peb 5, 2026 · NCT06809179Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Maitland
- GSK Investigational Site, Miami
- GSK Investigational Site, Stuart
Nagre-recruitPhase 2
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT07105709Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.